CARDIOMYOPATHY, DILATED
Clinical trials for CARDIOMYOPATHY, DILATED explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, DILATED trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, DILATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm showdown: ablation may beat drugs for ventricular tachycardia
Disease control OngoingThis trial tests whether a procedure called catheter ablation works better than anti-arrhythmic drugs for people with structural heart disease who have had a dangerous fast heart rhythm (ventricular tachycardia). About 162 participants will be randomly assigned to either ablation…
Matched conditions: CARDIOMYOPATHY, DILATED
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study tracks rare genetic heart condition to guide future treatments
Knowledge-focused OngoingThis study follows about 35 people with dilated cardiomyopathy caused by a BAG3 gene mutation, a condition that weakens the heart muscle. Over three years, researchers will monitor heart function, symptoms, and quality of life using tests like imaging and blood work. The goal is …
Matched conditions: CARDIOMYOPATHY, DILATED
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New heart study aims to cut unnecessary pacemaker implants by half
Knowledge-focused OngoingThis study tests whether using an ultrasound measure of heart muscle coordination (mechanical dyssynchrony) can better select heart failure patients for cardiac resynchronization therapy (CRT) than current guidelines. About 500 patients will receive a CRT device, but pacing will …
Matched conditions: CARDIOMYOPATHY, DILATED
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC